Efficacy of conbercept pro re nata (PRN) versus treat-and-extend (T&E) regimens following five initial monthly doses in diabetic macular edema: a 24-month retrospective cohort study. [PDF]
Yang M +7 more
europepmc +1 more source
Systemic factors associated with poor anatomical response to anti-VEGF therapy in patients with diabetic macular edema: evidence from a large clinical cohort. [PDF]
Jia X, Shi Y, He M, Yao D, Lin C.
europepmc +1 more source
Real-world cost evaluation of conbercept vs. ranibizumab for retinal and choroidal vascular diseases from 2021 to 2024: evidence from societal and medical insurance perspectives. [PDF]
Liu Y +12 more
europepmc +1 more source
Clinical efficacy of Conbercept combined with pars plana vitrectomy for proliferative diabetic retinopathy. [PDF]
Chen Y, Wang M, Gao J.
europepmc +1 more source
COMPARE COMBINED USE OF ANTI-VEGF DRUGS DURING OR AFTER PARS PLANA VITRECTOMY FOR DIABETIC MACULAR EDEMA GUIDED BY MICROSCOPE-INTEGRATED OPTICAL COHERENCE TOMOGRAPHY. [PDF]
Zhu J, Liu J, Chen YX, Yang XW, Zhu RR.
europepmc +1 more source
Macular Telangiectasia type 1 treated with integrated traditional Chinese acupuncture and Conbercept: a case report. [PDF]
Liu Z +5 more
europepmc +1 more source
Cost-effectiveness analysis of the use of faricimab in diabetic macular edema in China. [PDF]
Shi F +6 more
europepmc +1 more source
Tetrahedral DNA nano-PROTACs enable enhanced ocular penetration and efficient nucleolin degradation for choroidal neovascularization therapy. [PDF]
Song J +14 more
europepmc +1 more source
Research advances in the translational application of anti-VEGF combined with subthreshold micropulse laser therapy for refractory diabetic macular edema. [PDF]
Wang D, Wei D, Zhang F, Liu C.
europepmc +1 more source
Case report: Two cases of juxtapapillary retinal capillary hemangioma treated with intraocular cryotherapy. [PDF]
Zhang W, Yang Y, Ren C, Jiang X, Lu F.
europepmc +1 more source

